EUHASS is a pharmacovigilance program to monitor the safety of treatments for people with inherited bleeding disorders in Europe.
Haemophilia treatment centres report adverse events directly to the EUHASS website and regular surveillance reports are produced.
Directory of Clotting Factor Products Used in Europe
|Access the directory|
EUHASS Systems Login
IT Systems Support
|+44(0) 161 277 7917|